WorldPharmaNews
  • Home
  • Business
  • Research
  • Jobs
  • Events
  • Regulatory

Allergan plc confirms discussions regarding potential business combination transaction with Pfizer Inc.

Details
Financial
29 October 2015
Allergan plc today confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction. Allergan stated that no agreement has been reached and there can be no certainty that these discussions will lead to a transaction, or as to the terms on which a transaction, if any, might be agreed.
Read more ...

AstraZeneca rejects final proposal from Pfizer

Details
Financial
19 May 2014
The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal to combine the two companies. Leif Johansson, Chairman of AstraZeneca mentioned that the final proposal is a minor improvement which continues to fall short of the Board's view of value and has been rejected.
Read more ...

Pfizer announcement and AstraZeneca statement

Details
Financial
13 May 2014
Pfizer wishes to enter into discussions with AstraZeneca regarding a potential combination of the two companies and is "disappointed at the lack of engagement by the AstraZeneca Board". The Board of AstraZeneca notes the announcement made by Pfizer and states that the "announcement contains no new proposal nor substantive new information."
Read more ...

Forest Laboratories to Acquire Clinical Data, Inc.

Details
Financial
22 February 2011
Forest LaboratoriesForest Laboratories, Inc. (Forest) (NYSE: FRX) and Clinical Data, Inc. (Clinical Data) (NASDAQ: CLDA) have entered into a definitive merger agreement pursuant to which Forest will acquire Clinical Data, a specialty pharmaceutical company focused on the development of first-in-class and best-in-category therapeutics,
Read more ...

Convergence Pharmaceuticals Successfully Launched out of GSK to Focus on Novel High Value Analgesics

Details
Financial
07 October 2010
Convergence Pharmaceuticals Ltd, a new company focused on the development of novel and high value analgesic medicines, was officially launched and has successfully raised $35.4 million (£22.4 million) in Series A financing from a syndicate of leading European and US life science investors. Convergence Pharmaceuticals is an independent biotechnology company that has acquired clinical assets from GlaxoSmithKline ("GSK").
Read more ...

Mylan to Acquire Bioniche Pharma Global Injectable Pharmaceuticals Business

Details
Financial
16 July 2010
Mylan Inc. (Nasdaq: MYL) has announced plans to acquire Bioniche Pharma Holdings Limited, a privately held, global injectable pharmaceutical company for $550 million in cash.
Read more ...

Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.

Details
Financial
20 May 2010
Astellas Pharma Inc.Astellas Pharma Inc. (TSE: 4503), a global pharmaceutical company, and OSI Pharmaceuticals, Inc. (Nasdaq: OSIP), a biotechnology company primarily focused on the discovery, development and commercialization of molecular targeted therapies addressing medical needs in oncology, diabetes and obesity, have entered into a definitive merger agreement under which Astellas will acquire OSI.
Read more ...

More Pharma News ...

  1. ratiopharm to become the hub for Teva's European growth strategy
  2. Johnson & Johnson Reports Full-Year and Fourth-Quarter 2008 Results
  3. Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
  4. Alpharma Responds To Unsolicited Proposal By King Pharmaceuticals, Inc.
  5. King Proposes Acquisition of Alpharma for $33 Per Share in Cash
  6. Teva Reports Second Quarter 2008 Results - Record Quarterly Sales of $2,823 Million
  7. Grindeks profit reaches 5 million lats in the first half of 2008
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next
  • End
admet_300x250

Business & Industry

  • FDA grants Breakthrough Therapy Designation for Roche's Hemlibra in haemophilia A without inhibitors
  • Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials
  • Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford
  • Bristol-Myers Squibb announces worldwide collaboration with Janssen to develop and commercialize next-generation cardiovascular therapy
  • GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics

Research & Development

  • Personalized tumor vaccine shows promise in pilot trial
  • New class of drugs could help tackle treatment-resistant cancers
  • New immunotherapy for lung cancer shows promise of success
  • Human drug trials are compromised by poor reporting of animal research
  • 'Coffee filter' helps make new cancer drug Z-endoxifen 1,000 times cheaper
  • Researchers propose key elements of antimicrobial stewardship for hospitals worldwide
  • When drugs are wrong, skipped or make you sick: The cost of non-optimized medications

Conferences & Events

  • SMi presents the 2nd annual conference on Pharmaceutical Microbiology West Coast
  • Introducing SMi's 6th annual conference on Pharmaceutical Freeze Drying Technology this June 2018
  • Adaptive Designs in Clinical Trials Conference 2018
  • Drug Safety 2018
  • Controlled Release Delivery Conference 2018
  • Superbugs & Superdrugs Conference 2018
  • Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference 2018

Regulatory Affairs

  • FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
  • FDA approves new treatment for certain digestive tract cancers
  • FDA approves first treatment for breast cancer with a certain inherited genetic mutation
  • FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response
  • FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
  • FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care
  • FDA launches public education campaign to encourage adult smokers trying to quit cigarettes
  1. You are here:  
  2. Home
  3. Financial

About

  • Home
  • Advertise
  • Privacy
  • Terms of Use
  • Contact

Submit Your News!

Latest WORLD PHARMA JOBS

  • Senior Clinical Data Manager
  • Director Technology Strategy and Innovation

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • Google+
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2006 - 2017. All Rights Reserved. Our top projects: World Pharma News | WORLD PHARMA JOBS | PharmaNews.eu | eHealthNews.eu | (HEALTH IT) SPACE